期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 123, 期 1, 页码 11-18出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI62876
关键词
-
资金
- NIH
- Leducq Foundation
- Robert A. Welch Foundation
- American Heart Association: Jon Holden DeHaan Foundation
- National Heart, Lung, and Blood Institute [1F30HL103013]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL103013, R01HL093039, R01HL077439, R01HL111665] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099653] Funding Source: NIH RePORTER
The management of cardiovascular risk through lifestyle modification and pharmacotherapy is paramount to the prevention of cardiovascular disease. Epidemiological studies have identified obesity, dyslipidemia, diabetes, and hypertension as interrelated factors that negatively affect cardiovascular health. Recently, genetic and pharmacological evidence in model systems has implicated microRNAs as dynamic modifiers of disease pathogenesis. An expanded understanding of the function of microRNAs in gene regulatory networks associated with cardiovascular risk will enable identification of novel genetic mechanisms of disease and inform the development of innovative therapeutic strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据